Lexicon Pharma (LXRX) – Corporate News
-
Lexicon Pharma (LXRX) Announces 57.66M Share Offering by Selling Stockholders
-
Lexicon Pharma (LXRX) Announces New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and CKD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LXRX Stock Lookup